Press Release

Press Release | Jun 22, 2021

Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced that it has received FDA 510(k) clearance for its modular collar portfolio featuring the Company’s BioGrip® 3D-printed implant technology. The patented design, now available as part of the ELEOSTM Limb Salvage System, was created to help address the clinical challenge of aseptic loosening (also

Press Release, Uncategorized | Jun 11, 2021

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced it has closed the previously announced sale of its miraDry business to 1315 Capital, a healthcare growth equity firm investing in commercial stage companies across medical devices, healthcare services, and therapeutics. The transaction was previously described in

Press Release | May 26, 2021

Aktana, the global leader in intelligent customer engagement for the life sciences industry, announced a strategic investment in its mission to elevate the omnichannel experience for healthcare professionals (HCPs) with its appointment of Bingqian Gao as senior director of global advanced analytics. Prior to Aktana, Bingqian led the data science team at TrueCue, an analytics

Press Release | May 26, 2021

Colorescience®, a leading dermatologist-recommended skincare company, is pleased to announce the launch of two new additions to its award-winning Total Protection™ Face Shield line of all-mineral sunscreens.  New Face Shield Flex SPF 50 ($45) and Face Shield Matte SPF 50 ($39) feature the brand’s proprietary EnviroScreen® Technology to provide comprehensive protection from environmental aggressors.

Press Release | May 11, 2021

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced it has entered into a definitive agreement to sell its miraDry business to 1315 Capital, a healthcare growth equity firm investing in commercial stage companies across medical devices, healthcare services, and therapeutics. Subject to certain terms and

Press Release | May 04, 2021

Verogen Inc. announced today that it is debuting an affordable entry point to NGS on the MiSeq FGx® Sequencing System with the commercial launch of the ForenSeq MainstAY Workflow. The kit targets the core autosomal and Y-STR loci accepted by global databases, minimizing the need to validate additional markers. With two kit sizes and support for volume

Press Release | May 03, 2021

Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) announced today that eviCore Healthcare (“eviCore”), a wholly owned subsidiary of Cigna, has updated their laboratory management guidelines to include positive coverage for ThyGeNEXT® and ThyraMIR®. This update, which impacts approximately 27 health plans nationwide covering 100 million lives, is effective on July 1, 2021. This means

Press Release | Apr 29, 2021

In celebration of Patient Experience Week (April 26-30, 2021), Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced ongoing growth and adoption of its patient-centric innovations. These solutions are designed to help improve patient outcomes and experiences using the latest in precision anatomic modeling, 3D printing, design innovation, and

Press Release | Apr 07, 2021

Bonafide, the company pioneering mainstream medical use of drug-free, naturally derived health solutions for menopause, announces today that Dr. Alyssa Dweck will join its team as its Chief Medical Officer. Bonafide’s products are already trusted by over 9,000 unpaid health care professionals – primarily OBGYNs –  and 70,000+ women.

Press Release | Mar 30, 2021

Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today that it has expanded its capabilities to address the orthoplastics market by incorporating its recently introduced Sequel line of external fixators to complement its existing wound debridement and regenerative products

Pages 1 2 3 4 12